Roadmap to Cytotoxicity: Exploring Assays and Mechanisms

Area of Science:

• Biomedical Research
• Toxicology
• Drug Development

Background:

• Cytotoxicity assays are crucial for evaluating cellular responses to various stimuli.
• They play a significant role in understanding disease mechanisms and advancing drug discovery.
• A comprehensive understanding of these assays is vital for safety and efficacy studies.

Purpose of the Study:

• To review a wide spectrum of cytotoxicity assays, from basic to advanced techniques.
• To discuss the significance and application of these assays in drug development, toxicology, and biomedical research.
• To explore emerging technologies and future challenges in the field.

Main Methods:

• Review of established cytotoxicity assays: Trypan blue, MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide), caspase activity, Lactate dehydrogenase release, comet, and micronucleus assays.
• Discussion of other relevant assays: Alamar Blue, Bromodeoxyuridine incorporation, and clonogenic cell survival.
• Exploration of novel technologies: chip-based assays, organ-on-a-chip systems, and high-throughput screening.

Main Results:

• Detailed examination of the utility of various cytotoxicity assays in assessing cellular health and damage.
• Highlighting the importance of these assays in ensuring the safety and efficacy of potential drug candidates.
• Identification of emerging technologies that offer enhanced precision and efficiency in cytotoxicity testing.

Conclusions:

• Cytotoxicity assays are indispensable tools in modern biomedical research and drug development.
• The field is evolving with the integration of advanced techniques and technologies.
• Standardization and development of refined models are necessary to overcome existing challenges.